“Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release” (2025) Journal of Carcinogenesis, 24(7s), pp. 866–877. doi:10.64149/J.Carcinog.24.7s.866-877.